Iressa (Generic Gefitinib): Complete Medication Guide
Key Takeaways
Gefitinib is a targeted cancer medication that blocks specific proteins that help lung cancer cells grow.
It's used to treat certain types of non-small cell lung cancer (NSCLC) in adults with specific genetic mutations.
Common side effects include diarrhea, skin rash, and nausea, which are usually manageable.
The generic version works the same way as the brand-name Iressa but costs significantly less.
Regular monitoring by your oncology team is essential to track effectiveness and manage any side effects.
Gefitinib Overview
Gefitinib is a targeted therapy drug that belongs to a class of medications called tyrosine kinase inhibitors (TKIs). It works by blocking specific proteins called EGFR (epidermal growth factor receptor) that help certain lung cancer cells grow and divide. By stopping these proteins, gefitinib slows or stops the growth of cancer cells in people with specific genetic mutations.
This medication is primarily used to treat advanced non-small cell lung cancer (NSCLC) in patients whose tumors have specific EGFR mutations. It may be used as a first-line treatment or after other cancer therapies. Gefitinib is taken as an oral tablet, making it convenient for patients who prefer not to receive intravenous chemotherapy.
The generic version of gefitinib is bioequivalent to the brand-name Iressa, meaning it contains the same active ingredient and works identically in your body. Understanding the differences between generic vs brand-name drugs can help you make informed decisions about your cancer treatment while managing costs. This information is educational and does not replace advice from your healthcare provider.
Side Effects
Gefitinib is generally well-tolerated, but like all medications, it can cause side effects. Most side effects are manageable and may improve over time as your body adjusts to the medication. Your oncology team can help you manage symptoms and adjust your treatment if needed.
Common Side Effects
Diarrhea — The most frequent side effect; usually mild to moderate and manageable with dietary changes and over-the-counter remedies
Skin rash — Often appears on the face, chest, or back; usually mild and improves with proper skin care
Nausea and vomiting — May occur, especially early in treatment; anti-nausea medications can help
Loss of appetite — May contribute to weight loss; eating smaller, frequent meals can help
Dry skin — Common and manageable with moisturizers and gentle skincare products
Fatigue — Mild tiredness that usually improves with rest and activity management
Serious Side Effects
Severe diarrhea — Persistent or severe diarrhea that leads to dehydration or electrolyte imbalances
Severe allergic reactions — Rare but can include swelling of the face, lips, or throat requiring immediate medical attention
Liver problems — Elevated liver enzymes or liver damage, requiring regular blood work monitoring
Lung problems — Shortness of breath or interstitial lung disease, though this is uncommon
Eye problems — Corneal erosion or ulceration, which may cause eye pain or vision changes
When to Seek Medical Attention
Contact your healthcare provider immediately if you experience severe diarrhea lasting more than a few days, difficulty breathing, chest pain, severe allergic reactions, or persistent eye pain or vision changes. Additionally, report any signs of liver problems such as yellowing of the skin or eyes, dark urine, or severe abdominal pain. Your oncology team needs to know about any new or worsening symptoms so they can adjust your treatment plan accordingly.
Dosage
Dose Level or Form |
Dose |
Key Detail |
Standard dose |
250 mg once daily |
Most common starting dose for EGFR-mutated NSCLC |
Dose adjustment |
250 mg to 500 mg or reduced |
May be adjusted based on side effects or effectiveness |
With strong CYP3A4 inhibitors |
May require adjustment |
Certain medications can increase gefitinib levels in your body |
Hepatic impairment |
Dose reduction possible |
Patients with liver problems may need lower doses |
Renal impairment |
Usually no adjustment needed |
Kidney function typically doesn't require dose changes |
Important: Take gefitinib exactly as prescribed by your oncologist. Do not stop taking this medication without discussing it with your doctor, as stopping suddenly could allow cancer cells to grow again. If you miss a dose, take it as soon as you remember unless it's almost time for your next dose—then skip the missed dose. Do not double up on doses. Keep all scheduled appointments and blood work to monitor your treatment progress.
Drug Interactions
Gefitinib can interact with other medications, supplements, and certain foods. Some interactions may decrease the effectiveness of gefitinib or increase the risk of side effects. Always inform your healthcare team about all medications and supplements you're taking.
Strong CYP3A4 Inhibitors (Ketoconazole, Erythromycin)
These medications can increase gefitinib levels in your blood, potentially raising the risk of side effects. Your doctor may need to adjust your gefitinib dose or choose a different medication to avoid this interaction.
Strong CYP3A4 Inducers (Rifampicin, St. John's Wort)
These substances can decrease gefitinib levels, making it less effective at fighting cancer cells. Your oncologist may need to increase your gefitinib dose or monitor your response more closely if you're taking these medications.
Antacids and H2 Blockers (Omeprazole, Ranitidine)
These medications reduce stomach acid, which can decrease how much gefitinib your body absorbs. Take gefitinib at least 12 hours before or after these medications to minimize interaction.
Warfarin (Blood Thinner)
Gefitinib may increase the blood-thinning effects of warfarin, raising the risk of bleeding. Your doctor will monitor your INR levels and may adjust your warfarin dose accordingly.
Methotrexate (Cancer Drug)
Using gefitinib with methotrexate may increase the risk of liver damage and other serious side effects. Your oncology team will carefully monitor you if both drugs are necessary.
Continue Learning
Related articles you might find helpful
Pros and Cons
Pros
Targeted therapy — Works specifically against cancer cells with EGFR mutations, potentially offering better results with fewer side effects than traditional chemotherapy
Oral medication — Easy to take as a pill at home instead of requiring intravenous infusions at a hospital
Established efficacy — Proven to improve survival and progression-free survival in patients with EGFR-mutated NSCLC
Generic availability — The generic version offers cost-effective alternative to brand-name drugs while maintaining the same effectiveness
Manageable side effects — Most common side effects are mild to moderate and can be controlled with supportive care
Cons
Skin rash — Affects many patients and can be uncomfortable, though usually manageable with skincare
Diarrhea — The most common side effect that may require dietary changes or medication management
Drug interactions — Requires careful monitoring with other medications you may be taking
Regular monitoring needed — Requires frequent blood tests and doctor visits to monitor effectiveness and side effects
Serious but rare side effects — Lung problems and liver damage, while uncommon, require immediate medical attention if they occur
Frequently Asked Questions
Get answers to common questions about Gefitinib.
Yes, generic gefitinib contains the same active ingredient and works identically to brand-name Iressa. The FDA requires generic drugs to meet strict standards for quality, strength, and purity. Understanding generic vs brand-name drugs helps you make informed decisions about your cancer treatment while potentially saving thousands of dollars.
You'll typically take gefitinib as long as it's controlling your cancer and you're tolerating the side effects well. Your oncologist will monitor your progress with imaging tests and blood work to determine if the medication is working effectively. Never stop taking gefitinib without discussing it with your doctor first, as this could allow cancer cells to grow again.
Gefitinib can be taken with or without food, but consistency matters. If you take it with food one day, try to take it with food every day to maintain consistent absorption levels. Take it at the same time each day to help you remember and to keep steady medication levels in your body.
If you miss a dose, take it as soon as you remember unless it's almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule the next day. Never double up on doses to make up for a missed one, as this could increase the risk of side effects.
Gefitinib is a targeted therapy that slows or stops cancer cell growth in people with EGFR mutations, but it's not typically considered a cure. It aims to extend survival and improve quality of life. Your oncologist will discuss your specific prognosis and treatment goals based on your cancer stage and genetic profile.
The Bottom Line
Gefitinib is a targeted cancer therapy designed specifically for non-small cell lung cancer patients with EGFR mutations. When taken as prescribed, it offers a proven way to slow cancer growth while being taken as an oral medication at home. The generic version provides cost-effective alternative to brand-name drugs without sacrificing effectiveness. While side effects like diarrhea and skin rash are common, they're usually manageable with proper support and monitoring. Success with gefitinib requires regular communication with your oncology team, consistent medication adherence, and awareness of any serious warning signs. Getting clarity on your treatment plan helps you take control of your health journey.
Ready to take control of your health? Get started with Doctronic today. Our AI-authorized medical consultations are available 24/7, with options for $39 video visits or $19 text consultations with typical 4-minute wait times. Doctronic has guided over 22 million consultations with 99.2% treatment alignment with physicians—all HIPAA compliant and anonymous by default.
